Clinical Perspectives

Q&A: Dr. Gustainyte Explains Uterine Fibroid Embolization Procedure in Patients with Uterine Fibroids

Moffitt physicians in the Department of Diagnostic Imaging and Interventional Radiology are highly specialized in performing uterine fibroid...

New Study on Management and Treatment of Vaginal Mucosal Melanoma

Moffitt researchers conduct an immune monitoring study to determine immunotherapy responses in vaginal mucosal melanoma patients.

Highlights of Moffitt Science Presented at Tandem Meetings of ASTCT and CIMBTR

Moffitt scientists are presenting advances in areas like cellular immunotherapy for relapsed or refractory (R/R) acute myeloid leukemia (AML),...

New Clinical Trial Aims to Genomically Personalize Radiation Therapy for Breast Cancer

Moffitt researchers are testing the feasibility of genomically guided radiation therapy to improve outcomes in triple-negative breast cancer patients...

Q&A: Dr. Al-Roubaie Discusses Hemorrhoid Embolization Procedure in Treating Internal Hemorrhoids

Interventional Radiologist Dr. Al-Roubaie is specialized in treating internal hemorrhoids using the hemorrhoid embolization procedure, an approach...

Study Shows Seaweed Sugar (L-fucose) May Trigger Immune Responses That Combat Melanoma

Moffitt researchers discovered that administering oral L-fucose triggers potent antitumor immune responses that suppress tumors and enhance...

Moffitt's Endocrine Oncology Program Multidisciplinary Approach to Cancer Care

Moffitt's Endocrine Oncology Program is comprised of a multispecialty team of oncologists, surgeons, pathologists, and more who collaborate in a...

Health Insurance Literacy Study in Head and Neck Cancer Patients and Caregivers

Moffitt physicians participated in a pilot study monitoring the health insurance literacy levels of head & neck cancer patients and their caregivers.

Clinscience and OncoBay Clinical Partner to Expand Immuno-Oncology Research Globally

The Polish clinical research organization Clinscience made a major investment in OncoBay to partner on projects in the U.S. and Europe

Moffitt Partners with IBA for Proton Therapy

Moffitt partners with (Ion Beam Applications S.A., EURONEXT, to bring proton therapy to patients. This novel technology is impactful when treating...

Ovarian Transposition an Option for Fertility Preservation for Some Cervical Cancer Patients

For young women with cervical cancer, the possibility of losing the ability to have children can be a particularly challenging part of their...

Phase 1 Study Evaluating the Combination of 3 Immunotherapies in Metastatic HER2-Positive Breast Cancer Patients

Moffitt's Breast Oncology team assess a new Phase 1 HER2+ metastatic breast cancer trial combining T cell therapy following HER2-pulsed dendritic...

Knowing When Minimally Invasive Cancer Surgery is the Best Treatment Option Can Saves Lives

It’s vital that cancer surgeons understand when minimally invasive cancer surgery procedures are optimal for their patients and when they are not.

Predicting IPMN Pathology Using Noninvasive Radiogenomics

Dr. Jennifer Permuth is leading a study funded by the National Cancer Institute on early detection and prevention related to intraductal papillary...

Q&A: Dr. Mok Shares His Role as an Advanced Endoscopist

Dr. Shaffer Mok, a gastroenterologist and advanced endoscopist, shares advancements in the treatment of gastrointestinal cancers.